EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Old drugs with new applications: Tofacitinib-mediated inhibition of M1-like macrophage polarization in acute pancreatitis by the JAK/STAT and emerging NOD-like receptor pathways

Yunfei Dai, Hong Xiang, Fangyue Guo, Yu Wu, Liang Zhao, Xin Kong, Yao Xu, Dong Shang, Xufeng Tao

International Immunopharmacology · 2025

DOI: 10.1016/j.intimp.2025.115135 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2025. Verfasst von Yunfei Dai und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Integrative Medicine, The First Affiliated Hospital of Dalian Medical University, Dalian 116011, China; Institute (College) of Integrat…. Hauptthemen laut MEDLINE: Piperidines, Pyrimidines, Macrophages, Pancreatitis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Department of Science and Technology of Liaoning Province, Liaoning Provincial Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Given the potential for persistent inflammation to induce severe systemic inflammatory consequences, the development of new drugs for the early inflammatory cascade of acute pancreatitis (AP) is particularly important. The aim of this study was to investigate the activity of the JAK inhibitor tofacitinib (TOFA) against AP. METHODS: In vivo, TOFA efficacy against AP was assessed in a mouse model induced by the intraperitoneal injection of caerulein and retrograde pancreatic duct infusion of sodium taurocholate (STC). In vitro, we evaluated the effect of TOFA on the polarization of mouse macrophages (RAW264.7) exposed to lipopolysaccharide (LPS) alone or in combination with IFN-γ. In addition, to verify that TOFA improves AP via JAK/STAT inhibition, RNA-Seq was used to explore potential signalling cascades that inhibit M1 polarization. RESULTS: TOFA significantly improved pancreatic injury and the inflammatory response in two AP mouse models by inhibiting M1 macrophage polarization in vivo and in vitro. The inhibitory effects of TOFA were mediated by JAK/STAT pathway suppression (reducing p-STAT1 and p-STAT3). Furthermore, after the administration of filgotinib (a JAK1 inhibitor), TOFA still significantly inhibited macrophage M1 polarization. RNA-Seq, qPCR and Western blotting subsequently confirmed that TOFA also has inhibitory effects on the emerging NOD-like receptor signalling pathway. This is primarily reflected in the inhibition of GBP2, GBP5, NLRP3, GSDMD-N and CASP 1 protein expression. CONCLUSIONS: TOFA improves macrophage M1 polarization and the associated inflammatory storm stimulated by AP by inhibiting the primary JAK/STAT pathway and the emerging NOD-like receptor pathway. This study expands the new use of the old drug TOFA in the clinical treatment of AP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PiperidinesPyrimidinesMacrophagesPancreatitisJanus Kinase InhibitorsAnti-Inflammatory AgentsAnimalsMiceSignal TransductionRAW 264.7 CellsDisease Models, AnimalMaleMice, Inbred C57BLJanus KinasesSTAT Transcription FactorsMacrophage ActivationTaurocholic AcidCeruletideSTAT1 Transcription Factor

Stichwörter der Autor:innen

Acute pancreatitisDrug repurposingJAK inhibitorMacrophage polarizationTofacitinib

Substanzen

tofacitinibPiperidinesPyrimidinesJanus KinasesSTAT Transcription FactorsJanus Kinase InhibitorsAnti-Inflammatory AgentsTaurocholic AcidCeruletideSTAT1 Transcription Factor

Autor:innen und Institutionen

  • Laboratory of Integrative Medicine, The First Affiliated Hospital of Dalian Medical University, Dalian 116011, China; Institute (College) of Integrative Medicine, Dalian Medical University, Dalian 116044, China; Departm…
  • Laboratory of Integrative Medicine, The First Affiliated Hospital of Dalian Medical University, Dalian 116011, China; Department of General Surgery, The First Affiliated Hospital of Dalian Medical University, Dalian 116…
  • Laboratory of Integrative Medicine, The First Affiliated Hospital of Dalian Medical University, Dalian 116011, China; Institute (College) of Integrative Medicine, Dalian Medical University, Dalian 116044, China.
  • Department of General Surgery, The First Affiliated Hospital of Dalian Medical University, Dalian 116011, China.
  • College of Pharmacy, Dalian Medical University, Dalian 116044, China.
  • Department of Pharmacy, The First Affiliated Hospital of Dalian Medical University, 116011 Dalian, China. Electronic address: taoxufeng@dmu.edu.cn.

Förderung

  • Department of Science and Technology of Liaoning Province
  • Liaoning Provincial Natural Science Foundation

Zitieren

APA

Dai, Y., Xiang, H., Guo, F., Wu, Y., Zhao, L., Kong, X., Xu, Y., Shang, D., & Tao, X. (2025). Old drugs with new applications: Tofacitinib-mediated inhibition of M1-like macrophage polarization in acute pancreatitis by the JAK/STAT and emerging NOD-like receptor pathways. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2025.115135

Vancouver

Dai Y, Xiang H, Guo F, Wu Y, Zhao L, Kong X, et al. Old drugs with new applications: Tofacitinib-mediated inhibition of M1-like macrophage polarization in acute pancreatitis by the JAK/STAT and emerging NOD-like receptor pathways. International Immunopharmacology. 2025. doi:10.1016/j.intimp.2025.115135

BibTeX
@article{Dai2025,
  author = {Dai, Yunfei and Xiang, Hong and Guo, Fangyue and Wu, Yu and Zhao, Liang and Kong, Xin and Xu, Yao and Shang, Dong and Tao, Xufeng},
  title = {Old drugs with new applications: Tofacitinib-mediated inhibition of M1-like macrophage polarization in acute pancreatitis by the JAK/STAT and emerging NOD-like receptor pathways},
  journal = {International Immunopharmacology},
  year = {2025},
  doi = {10.1016/j.intimp.2025.115135}
}
Kostenlos starten →